Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma
To access this article, please choose from the options below
PII: S1368-8375(10)00118-1
doi:10.1016/j.oraloncology.2010.03.022
© 2010 Elsevier Ltd. All rights reserved.
